Process and Product Development, Amgen Inc., Thousand Oaks, California.
Biotechnol Bioeng. 2012 Nov;109(11):2770-7. doi: 10.1002/bit.24555. Epub 2012 May 28.
High levels of translational errors, both truncation and misincorporation in an Fc-fusion protein were observed. Here, we demonstrate the impact of several commercially available codon optimization services, and compare to a targeted strategy. Using the targeted strategy, only codons known to have translational errors are modified. For an Fc-fusion protein expressed in Escherichia coli, the targeted strategy, in combination with appropriate fermentation conditions, virtually eliminated misincorporation (proteins produced with a wrong amino acid sequence), and reduced the level of truncation. The use of full optimization using commercially available strategies reduced the initial errors, but introduced different misincorporations. However, truncation was higher using the targeted strategy than for most of the full optimization strategies. This targeted approach, along with monitoring of translation fidelity and careful attention to fermentation conditions is key to minimizing translational error and ensuring high-quality expression. These findings should be useful for other biopharmaceutical products, as well as any other transgenic constructs where protein quality is important.
高翻译错误水平,在 Fc 融合蛋白中都观察到截短和错参。在这里,我们展示了几种市售密码子优化服务的影响,并与靶向策略进行了比较。使用靶向策略,仅修改已知存在翻译错误的密码子。对于在大肠杆菌中表达的 Fc 融合蛋白,靶向策略与适当的发酵条件相结合,几乎消除了错参(产生具有错误氨基酸序列的蛋白质),并降低了截短水平。使用市售策略进行完整优化降低了初始错误,但引入了不同的错参。然而,使用靶向策略的截短水平高于大多数完整优化策略。这种靶向方法,以及对翻译保真度的监测和对发酵条件的仔细关注,是最大限度减少翻译错误并确保高质量表达的关键。这些发现对于其他生物制药产品以及任何其他蛋白质质量很重要的转基因构建体都应该是有用的。